The activation of the MAPK/ERK pathway is known to contribute to the immune evasion potential of tumor cells [50], which was further diminished by hesperidin and reduced secretion levels of MMP-9 and MMP-2 in high PD-L1 expressing tumor cells [223]. Here, MMP9 is linked to neoplasm.